• CLINICAL TRIALS

  • We have validated the efficacy of our digital therapeutics with on-going clinical trial studies.

  • Stress Resilience
    University of Toronto

     

    In a landmark study, researchers found that our digital therapeutics technology produced “significant improvement” stress resilience amongst university students who self-report anxiety, when compared to placebo. Analyses revealed a reduction of stress immediately after each training session compared with before the training session, and decreased post-session stress over 3 weeks.

    Attentional Control
    University of Toronto

     

    A study that tracked attention control in university students, found that our digital therapeutics technology, AmDTx, produced “long-term” benefits for attentional control compared to placebo, indicating that our app is effective for enhancing focus. Mindfulness training, relative to cognitive training, resulted in greater improvements in attentional control.

  • Psycho-oncology
    University of Calgary

     

    In a clinical trial with urban and rural cancer survivors, AmDTx provided stress reductions “similar in effect sizes of in-person programs,” indicating AmDTx provides medical-grade stress relief to cancer patients regardless of their location.

    Fear of Cancer Recurrence
    University of Calgary

     

    In a clinical trial with cancer patients, researchers investigated the potential for AmDTx to reduce the “fear of cancer recurrence”, a very serious burden on cancer survivors and their loved ones.

  • Physical Endurance
    University of Toronto

     

    Researchers examined the effect of mental training with AmDTx versus a control app on the total physical endurance of amateur athletes.

     

    Mental Response to High Intensity Exercise
    University of Toronto

     

    Researchers examined the mental response to High Intensity Exercise in amateur athletes who trained with AmDTx versus a control app, and have found some intriguing results important for exercise paradigm adherence.